IMAJ | volume 26
Journal 5, May 2024
pages: 294-298
1 Department of Neurology, Wolfson Medical Center, Holon, Israel
2 Department of Orthopedic Surgery, Wolfson Medical Center, Holon, Israel
3 Pediatric Neuromuscular Clinic and Pediatric Neurology Unit, Wolfson Medical Center, Holon, Israel
4 Abarbanel Mental Health Center, Bat Yam, Israel
5 Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel
Summary
Background:
The recreational use of nitrous oxide (N
2O) has increased in recent years with a noticeable surge in the incidence of nitrous oxide-related myeloneuropathy.
Objectives:
To raise awareness of increasing myeloneuropathy due to recreational nitrous oxide misuse in Israel.
Methods:
We conducted a case series documenting the clinical and investigative features of eight patients presenting with nitrous oxide-induced myeloneuropathy who were admitted to our departments.
Results:
Paresthesia was the chief complaint in all patients, with sensory gait ataxia being a common feature, which was often accompanied by Romberg's sign and mild lower limb weakness. Vitamin B12 levels were below the normal range in seven patients, accompanied by elevated homocysteine and methylmalonic acid levels.
Magnetic resonance imaging scans revealed hyperintense signals in the dorsal columns of the cervical spine. All patients improved following vitamin B12 injections.
Conclusions:
Enhancing awareness, prompting the use of appropriate investigations, and advocating for timely treatment are needed to overcome the risks associated with nitrous oxide misuse.